What Researchers Did
This review examined the effectiveness of various drug treatments for sensorineural hearing loss.
What They Found
Recent placebo-controlled trials showed no beneficial effects from rheological or vasodilative drugs, or hemodilution, in treating inner ear diseases. Experimental studies also found that while some drugs temporarily improved cochlear blood flow, most actually worsened cochlear oxygenation.
What This Means for Canadian Patients
For Canadian patients experiencing sensorineural hearing loss, this research suggests that common drug therapies like vasodilators or blood thinning agents may not be effective. Instead, focusing on treating any underlying health conditions is highlighted as the only current effective approach.
Canadian Relevance
No direct Canadian connection identified. Sensorineural hearing loss is not a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
This review from 1992 focuses solely on drug therapies and does not evaluate the potential role or limitations of hyperbaric oxygen therapy for sensorineural hearing loss.